- Location
alogliptin
"-
Japan-Based Takeda Pharma Has Received Positive CHMP Opinion
Jul 30, 2013Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...
Tags: Therapies, CHMP Opinion
-
Takeda Has Received FDA Approval for Three New Type 2 Diabetes Therapies Nesina
Jan 30, 2013Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals
-
Takeda Global Research & Development Center Has Resubmitted New Drug Applications
Dec 5, 2012Furiex Pharmaceuticals said Takeda Global Research & Development Center has resubmitted New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone ...
Tags: Furiex Pharmaceuticals, NDAs, alogliptin and pioglitazone
-
Takeda Receives Response From FDA Regarding Its New Drug Applications
Dec 4, 2012Takeda Pharmaceutical has received a complete response letter from the US Food and Drug Administration (FDA) regarding its new drug applications (NDAs) for alogliptin and the fixed-dose combination therapy alogliptin and pioglitazone. ...
Tags: FDA, alogliptin, clinical trial program
Related Products
-
Low Price with Good Quality Alogliptin Related Compound 28 CAS#865758-96-9
-
High Quality 850649-62-6 Alogliptin Benzoate
-
White Powder Alogliptin Benzoate 850649-62-6 Intermediates Pharmaceutical Intermediates Factory Direct
-
Alogliptin Benzoate 850649-62-6 High Quality and Competitive Price
-
Factory Supply Raw Material for Diabetes Treatment 850649-62-6 Alogliptin Benzoate
-
850649-62-6 Alogliptin Benzoate GMP Ep
